Product Information
SPIRIVA HANDIHALER 18 MCG CAP is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $10.6222 per EA under NDC 00597007547. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
18 ug/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597007547
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL; RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
TIOTROPIUM BROMIDE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA021395On Market Since
10/11/2005
Pharmacological Classes
Price Statistics
The NADAC for SPIRIVA HANDIHALER 18 MCG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.6222 per EA |
|---|---|
| All-time high | $16.3935 (Jan 1, 2025) |
| All-time low | $8.3755 (Nov 28, 2013) |
| 52-week high | $10.6389 |
| 52-week low | $10.6166 |
| Median price | $12.7033 |
| Average price | $12.9552 |
| Largest weekly change | -35.0% (Jan 8, 2025) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SPIRIVA HANDIHALER 18 MCG CAP?
The current National Average Drug Acquisition Cost (NADAC) for SPIRIVA HANDIHALER 18 MCG CAP, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $10.6222 per EA (NDC 00597007547), effective Jun 24, 2026.
How has the price of SPIRIVA HANDIHALER 18 MCG CAP changed over time?
Over the history we have for it, the NADAC for SPIRIVA HANDIHALER 18 MCG CAP has risen 26.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SPIRIVA HANDIHALER 18 MCG CAP?
Since Nov 28, 2013, the NADAC for SPIRIVA HANDIHALER 18 MCG CAP has ranged from a low of $8.3755 (Nov 28, 2013) to a high of $16.3935 (Jan 1, 2025), with a median of $12.7033 per EA.
Are there cheaper alternatives to SPIRIVA HANDIHALER 18 MCG CAP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SPIRIVA HANDIHALER 18 MCG CAP, is $10.6216 per EA — about 0% below SPIRIVA HANDIHALER 18 MCG CAP.
Who manufactures SPIRIVA HANDIHALER 18 MCG CAP?
SPIRIVA HANDIHALER 18 MCG CAP (NDC 00597007547) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification